Related Experiment Video
Updated: Sep 24, 2025
Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Multisystem Inflammatory Syndrome in Children: A Case Report From Japan
Masaki Hisamura1, Hikari Asai2, Noriyuki Sakata3
1Department of Emergency Medicine, Saitama Medical Center, Saitama Medical University, Kawagoe City, JPN.
Insights
This report details the first case of multisystem inflammatory syndrome in children (MIS-C) in Japan. Early identification is crucial for young patients presenting with fever and shock symptoms linked to COVID-19.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition associated with COVID-19.
- While not widespread in Japan, recognizing MIS-C is vital for pediatric care.
- Accurate diagnostic information for MIS-C is needed, especially given limited reported cases globally.
Observation:
- This study presents the first documented case of MIS-C in Japan.
- The patient was a child presenting with fever and shock, symptoms potentially linked to COVID-19.
- The case highlights the importance of considering MIS-C in pediatric patients with relevant symptoms.
Findings:
- The study confirms the occurrence of MIS-C in Japan.
- It provides valuable clinical information for diagnosing MIS-C in a Japanese pediatric population.
- This case report contributes to the global understanding of MIS-C epidemiology and presentation.
Implications:
- This report serves as a critical alert for Japanese healthcare providers to consider MIS-C.
- It emphasizes the need for heightened awareness and diagnostic preparedness for MIS-C in children.
- The findings support the development of targeted diagnostic and management strategies for MIS-C in Japan.
Abstract:
This study reports a case of multisystem inflammatory syndrome in children (MIS-C). Although MIS-C is currently not widespread in Japan, it is important to consider this syndrome, particularly when the patient is younger than 21 years and presents with fever and shock symptoms associated with COVID-19. According to the latest statistics updated by the Centers for Disease Control and Prevention in early 2021, the total number of MIS-C patients is only 1659 and there have been no reports from Japan. Therefore, information to accurately diagnose MIS-C is needed. This study is the first case report of MIS-C in Japan, and it proposes information to identify this serious syndrome.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018